Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-25-040407
Filing Date
2025-05-07
Accepted
2025-05-07 07:58:31
Documents
4

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea0237688-424b5_chinasxt.htm 424B5 382955
2 GRAPHIC image_001.jpg GRAPHIC 26510
3 GRAPHIC image_002.jpg GRAPHIC 60973
4 GRAPHIC image_003.jpg GRAPHIC 8114
  Complete submission text file 0001213900-25-040407.txt   516003
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 424B5 | Act: 33 | File No.: 333-282776 | Film No.: 25919373
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)